1. Home
  2. Labeler Index
  3. Sun Pharmaceutical Industries, Inc.
  4. 47335-177
  5. NDC Package Code: 47335-177-95 Ilumya

NDC Package 47335-177-95 Ilumya

Tildrakizumab-asmn Injection, Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Other Packages
    4. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
47335-177-95
Package Description:
1 mL in 1 CARTON
Product Code:
47335-177
Proprietary Name:
Ilumya
Non-Proprietary Name:
Tildrakizumab-asmn
Substance Name:
Tildrakizumab
Usage Information:
This medication is used to treat moderate to severe plaque psoriasis. Tildrakizumab-asmn belongs to a class of drugs known as monoclonal antibodies. It works by blocking a certain natural substance in your body (interleukin-23) that may lead to the overgrowth of skin cells and redness/swelling seen in plaque psoriasis. Tildrakizumab-asmn can help lessen the symptoms of plaque psoriasis, including red, scaly, itchy patches of skin.
11-Digit NDC Billing Format:
47335017795
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
1 ML
NDC to RxNorm Crosswalk:
  • RxCUI: 2053453 - tildrakizumab-asmn 100 MG in 1 ML Prefilled Syringe
  • RxCUI: 2053453 - 1 ML tildrakizumab-asmn 100 MG/ML Prefilled Syringe
  • RxCUI: 2053453 - tildrakizumab-asmn 100 MG per 1 ML Prefilled Syringe
  • RxCUI: 2053458 - ILUMYA 100 MG in 1 ML Prefilled Syringe
  • RxCUI: 2053458 - 1 ML tildrakizumab-asmn 100 MG/ML Prefilled Syringe [Ilumya]
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Sun Pharmaceutical Industries, Inc.
    Dosage Form:
    Injection, Solution - A liquid preparation containing one or more drug substances dissolved in a suitable solvent or mixture of mutually miscible solvents that is suitable for injection.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • TILDRAKIZUMAB 100 mg/mL
    • Pharmacologic Class(es):
  • Interleukin-23 Antagonist - [EPC] (Established Pharmacologic Class)
  • Interleukin-23 Antagonists - [MoA] (Mechanism of Action)
    • Sample Package:
    No
    FDA Application Number:
    BLA761067
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    08-06-2018
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 47335-177-95 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    47335017795J3245Inj., tildrakizumab, 1 mg1 MG11100100

    * Please review the disclaimer below.

    Other Product Packages

    The following packages are also available for this product:

    NDC Package CodePackage Description
    47335-177-011 mL in 1 SYRINGE, GLASS
    47335-177-101 mL in 1 CARTON
    47335-177-961 mL in 1 SYRINGE, GLASS

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 47335-177-95?

    The NDC Packaged Code 47335-177-95 is assigned to a package of 1 ml in 1 carton of Ilumya, a human prescription drug labeled by Sun Pharmaceutical Industries, Inc.. The product's dosage form is injection, solution and is administered via subcutaneous form.This product is billed per "ML" milliliter and contains an estimated amount of 1 billable units per package.

    Is NDC 47335-177 included in the NDC Directory?

    Yes, Ilumya with product code 47335-177 is active and included in the NDC Directory. The product was first marketed by Sun Pharmaceutical Industries, Inc. on August 06, 2018 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 47335-177-95?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 47335-177-95?

    The 11-digit format is 47335017795. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-247335-177-955-4-247335-0177-95